EMA
guidance
· 2014-10-24
Scenesse recommended for rare disease that causes intolerance to sunlight
Summary
EMA recommends Scenesse for a rare disease causing intolerance to sunlight, signaling regulatory consideration or support for the drug's use in this condition.
Upgrade for the full analysis, importance score, and drug timeline.